Piper Sandler raised the firm’s price target on Intuitive Surgical to $315 from $265 and keeps an Overweight rating on the shares following the "all-around Q1 beat." The analyst believes Intuitive is well positioned to deliver another year of strong execution in 2023 and "remains poised for durable best-in-class financial performance."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ISRG:
- Intuitive Surgical price target raised to $309 from $305 at RBC Capital
- Intuitive Surgical price target raised to $313 from $284 at BTIG
- Intuitive Surgical price target raised to $270 from $240 at Evercore ISI
- Intuitive Surgical price target raised to $285 from $265 at Morgan Stanley
- Intuitive Surgical price target raised to $325 from $300 at Truist
